Disparities in Growth Hormone Deficiency Screening, Evaluation, Diagnosis, and Treatment Among at‐Risk Childhood Cancer Survivors in the US
We observed differences based on socioeconomic status, RT type, and age of cancer diagnosis in the likelihood of GHD screening, evaluation, diagnosis, and treatment, suggesting the need to investigate contributors to these disparities.
Authors
- Arnold C. Paulino (ORCID: https://orcid.org/0000-0002-0269-3045)
- Meghan Craven (ORCID: https://orcid.org/0000-0001-9727-6123)
- M. Fatih Okcu
- Vincent E. Horne (ORCID: https://orcid.org/0000-0002-4276-7985)
- Austin L. Brown (ORCID: https://orcid.org/0000-0001-5802-5073)
- Maria Monica Gramatges (ORCID: https://orcid.org/0000-0002-0947-104X)
- David Steffin (ORCID: https://orcid.org/0000-0002-0881-3167)
- Fulfilled Ighalo
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Baylor College of Medicine (US)
- Texas Children's Hospital (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1002/pbc.32124
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00